Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
734.97 | -46.29% | -24.25% | 661,770.95 | 0.69% | 2.63% |
|
NYSE:JNJ
Johnson & Johnson
|
149.27 | 0% | 0% | 359,245 | 3.31% | 2.71% |
|
NYSE:MRK
Merck
|
127.51 | -7.42% | 6.15% | 322,986.42 | 2.4% | -19.03% |
|
NYSE:PFE
Pfizer
|
27.81 | 11.74% | 42.95% | 157,475.27 | 6.06% | -9.31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
401.08 | 8.66% | 17.27% | 103,662.87 | 0% | 30.14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
957.00 | -27.73% | -21.57% | 105,447.53 | 0% | 13.9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
43.99 | 61.89% | 72.23% | 89,172.13 | 5.49% | 13.54% |
|
NYSE:ZTS
Zoetis
|
167.07 | 32.43% | 48.83% | 76,342.17 | 1.03% | 11.19% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
152.33 | 0% | 0% | 19,268.49 | 0% | 0% |
|
NYSE:BAX
Baxter International Inc
|
36.89 | 74.74% | 101.09% | 18,798.41 | 3.14% | -3.14% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.78 | 1.95% | 12.16% | 13,740.18 | 4.14% | -8.55% |
|
NasdaqGS:UTHR
United Therapeutics
|
262.40 | -9.47% | 0.04% | 11,641.77 | 0% | 5.22% |
|
NYSE:CTLT
Catalent
|
56.50 | -57.67% | -7.64% | 10,225.04 | 0% | -10.41% |
|
NasdaqGS:CYTK
Cytokinetics
|
65.27 | 0% | 0% | 6,838.6 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
41.97 | -,153.3% | -,146.3% | 6,121.15 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
150.40 | -0.56% | 9% | 4,561.9 | 0.54% | 5.85% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
229.84 | 0% | 0% | 4,342.48 | 0% | 0% |
|
NasdaqGS:NEOG
Neogen
|
12.02 | 135.45% | 235.73% | 2,670.77 | 0% | -1.7% |
|
LSE:INDV
Indivior PLC
|
14.35 | -23.61% | -1.68% | 1,952.43 | 0% | -2.7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
24.52 | -34.78% | -10.92% | 2,552.83 | 0% | 2.03% |
